Diagnostics
Multi-cancer early detection testing market to reach $7.52b by 2033
Multi-cancer early detection testing market to reach $7.52b by 2033
By end-user, hospitals and clinics accounted for $950m in 2024.
Global HPV and pap smear test market to hit $3.94b by 2030
The sector’s expansion is attributed to the rising number of HPV cases.
NUH, Siemens to study ultrasound tech for liver disease diagnostics
The initiative is part of the upcoming National University Centre for Digestive Health.
Diagnostics M&A activity to stay subdued in H2 amidst tariff uncertainty
Deal volume slowed after the first quarter.
NTUH unveils AI-powered diagnostic system for pancreatic cancer
The tool is available as a self-pay AI image analysis service.
Burjeel Holdings, Genalyte partner to introduce automated diagnostic system
The Merlin system is designed to deliver lab-accurate diagnostics in under 30 minutes.
SGH unveils new imaging technique to detect rare pancreatic tumours
Exendin-4 imaging highlights tumours as distinct bright spots during PET/CT scans.
Global HIV diagnosis market to be valued at $5.31b by 2030
However, high costs and complex testing procedures may limit growth.
AsiaMedic and Sunway open new imaging centre in Novena
The facility focuses on sub-specialised radiology fields.
Point-of-care diagnostics market to reach $65.9b by 2029
It is expected to grow at a CAGR of 10.2% during the forecast period.
Australian gov’t appoints contractor for Hedland MRI suite
The suite will include rooms for scanning, control, and anaesthetic preparation.
APAC malaria diagnostics market to grow at 6.1% CAGR through 2030
It is poised to witness the fastest growth amongst other regions.
Thomson Medical unveils urgent care centre for non-emergency conditions
The facility offers diagnostic services supported by the Thomson Diagnostic Imaging Centre.
What factors drive the global prostate cancer diagnostics market?
One key factor is the emergence of technologies such as liquid biopsies and genomic testing.
UAE diagnostic labs market to be valued at $1.46b by 2029
Key drivers include investments in advanced technologies and government support.
Head and neck cancer diagnostics market to grow by $6.3b by 2028
The sector is experiencing an upward trend in immunotherapy use.
Singapore-developed dementia screening tool goes global
The VCAT addresses the challenges of dementia screening in multi-lingual countries.